WinstonWınston
Back
Stock

Iveco Group N.V.

IVG.MI
36
Auto - Manufacturers · Consumer Cyclical
Price
€14.04
+0.04 (+0.29%)
Market Cap
€3.74B
Exchange
Italian Stock Exchange
Winston Score
36
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Sep 6, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
Growth
Good
Cash Flow
Weak
Stability
Weak
Valuation
Good
Dividends
Mixed

Share count falling — buybacks

1.4% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 271.0M (2021) → 267.3M (2025)

§Winston Score History

The full picture

Iveco Group is a European manufacturer of commercial vehicles, buses, and specialty vehicles. Its brands include IVECO (trucks and vans), Heuliez Bus, and IVECO Defence Vehicles, serving logistics companies, public transit operators, and military customers. The company was spun off from CNH Industrial in 2022 and is headquartered in Turin, Italy.

Iveco makes money by selling vehicles and providing aftermarket parts, services, and financing. It operates mainly in Europe, Latin America, and Africa, with a strong position in medium and heavy trucks across those regions. The company is investing in alternative powertrains, including natural gas, battery-electric, and hydrogen fuel cell vehicles, which represents a key growth opportunity. However, thin operating margins and exposure to economic cycles in commercial vehicle demand remain notable risks.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.3%
Thin — 13.3% gross margin
Profit after running costs
Operating Margin
3.7%
Thin — 3.7% operating margin
Return on the money invested
ROCE
5.3%
Weak — 5.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-7.4%
Shrinking sales (-7.4% YoY)
Profit growth
EPS YoY
+321.7%
Earnings growing fast (+321.7% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
31%
Weak — only 31% of profit becomes cash
Spare cash per sale
FCF Margin
-2.2%
Burning cash (-2.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.41
Heavy debt load (2.41)
Covers its interest
Interest Cover
1.42x
Dangerous — barely covers interest (1.4x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
2.8x
Attractive valuation — P/E 2.8

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
-8.5
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.35%
Moderate income — 2.35% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial